The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsChristian Mayr, Tobias Kiesslich|Oncotarget|2015Cited by 42
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract CancerDino Bekric, Christian Mayr|Cancers|2023Cited by 17
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cellsDino Bekric, Christian Mayr|PLoS ONE|2024Cited by 7